| RS2518507983 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518508012 |
PDHA1
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518508016 |
PDHA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518508058 |
PDHA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase complex deficiency |
| RS2518508076 |
PDHA1
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS2518511727 |
SNAP29
|
Health Risk |
Likely pathogenic |
— |
| RS2518511737 |
SNAP29
|
Health Risk |
Pathogenic |
— |
| RS2518513500 |
PHKA2
|
Health Risk |
Pathogenic |
— |
| RS2518515412 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS2518515512 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518515635 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518515672 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518515734 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518518071 |
SNAP29
|
Health Risk |
Pathogenic |
— |
| RS2518520358 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2518520486 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518520664 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518520815 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518520860 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518522174 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518522193 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518523051 |
TANGO2
|
Health Risk |
Pathogenic |
— |
| RS2518525425 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2518529289 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2518529653 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2518529916 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518542445 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS2518543955 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Nonpapillary renal cell carcinoma |
| RS2518545061 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518545084 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2518545485 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518545794 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518546071 |
NF2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2518546478 |
ITSN1
|
Health Risk |
Likely pathogenic |
— |
| RS2518547982 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2518548157 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518548162 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518548205 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518548238 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518551797 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518556881 |
NF2
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 2 |
| RS2518575127 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518575520 |
EIF2S3
|
Health Risk |
Likely pathogenic |
MEHMO syndrome, MEHMO syndrome |
| RS2518575579 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518575597 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518585587 |
CACNA1C
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2518590189 |
PDK3
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 6, Charcot-Marie-Tooth disease X-linked dominant 6 |
| RS2518592169 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2518592683 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518592712 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518592983 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS2518593055 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS2518593163 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS2518593223 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518593316 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2518593357 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS2518594021 |
DEPDC5
|
Health Risk |
Pathogenic |
See cases, See cases |
| RS2518594478 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2518594940 |
DEPDC5
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, familial focal |
| RS2518595115 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS2518595186 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS2518598543 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518600953 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2518603787 |
TBL1X
|
Health Risk |
Conflicting classifications of pathogenicity |
TBL1X-related disorder, Hypothyroidism |
| RS2518605910 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518606202 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
PHEX-related disorder, Thyroid cancer |
| RS2518606214 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS2518607537 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518607552 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518607554 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
LZTR1-related schwannomatosis, Hereditary cancer-predisposing syndrome |
| RS2518607568 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518607571 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518607576 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518607615 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518607641 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2518607656 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518607665 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518607691 |
LZTR1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518607763 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518607818 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 2, Noonan syndrome 2 |
| RS2518607819 |
LZTR1
|
Health Risk |
Likely pathogenic |
Familial multiple meningioma, Familial multiple meningioma |
| RS2518607851 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518607905 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2518607941 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2518607943 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518607997 |
LZTR1
|
Health Risk |
Likely pathogenic |
LZTR1-related schwannomatosis, LZTR1-related schwannomatosis |
| RS2518608027 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518608034 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518608539 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518608560 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
LZTR1-related disorder, Hereditary cancer-predisposing syndrome |
| RS2518608581 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518608604 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518609787 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518610578 |
LZTR1
|
Health Risk |
Likely pathogenic |
LZTR1-related schwannomatosis, LZTR1-related schwannomatosis |
| RS2518610602 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 10, Noonan syndrome 10 |
| RS2518610630 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518610661 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518612397 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2518612414 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2518612494 |
LZTR1
|
Health Risk |
Pathogenic |
— |